Hepatitis C Virus (HCV) is a significant global health concern, affecting millions of people worldwide. It is a bloodborne virus that primarily infects the liver, leading to chronic liver diseases such as cirrhosis and hepatocellular carcinoma. HCV is classified into seven major genotypes, each with multiple subtypes. Among these, Genotype 5 is relatively rare and predominantly found in Southern Africa .
HCV is an enveloped, positive-sense single-stranded RNA virus. Its genome encodes a single polyprotein, which is processed into structural and non-structural proteins. The structural proteins include the core protein and envelope glycoproteins E1 and E2, while the non-structural proteins include NS2, NS3, NS4A, NS4B, NS5A, and NS5B .
Genotype 5 of HCV is less common compared to other genotypes like 1, 2, and 3. It is mainly found in South Africa and has been associated with unique epidemiological and clinical characteristics. Understanding the genetic diversity and distribution of HCV genotypes is crucial for developing effective treatments and vaccines .
Recombinant HCV strains are formed when two different genotypes combine to create a mosaic genome. These recombinants can arise due to co-infection with multiple HCV genotypes or through viral recombination events. Recombinant strains can complicate diagnosis and treatment, as they may exhibit different resistance profiles and pathogenicity .
The core region of HCV is highly conserved and plays a critical role in the virus’s life cycle. Recombinant strains involving the core region of Genotype 5 have been identified, indicating the presence of intergenotypic recombination. These recombinants can provide insights into viral evolution and the mechanisms of HCV diversity .
Accurate genotyping of HCV is essential for effective therapeutic management. Genotyping based on the core and NS5B regions is considered the gold standard. Identifying recombinant strains requires sequencing multiple genomic regions to detect discordant genotypes. This approach helps in understanding the epidemiology of HCV and tailoring treatment strategies .